|
1
|
Kepler CK, Ponnappan RK, Tannoury CA,
Risbud MV and Anderson DG: The molecular basis of intervertebral
disc degeneration. Spine J. 13:318–330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Global Burden of Disease Study 2013
Collaborators: Global, regional, and national incidence,
prevalence, and years lived with disability for 301 acute and
chronic diseases and injuries in 188 countries, 1990–2013: A
systematic analysis for the Global Burden of Disease Study 2013.
Lancet. 386:743–800. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vo N, Niedernhofer LJ, Nasto LA, Jacobs L,
Robbins PD, Kang J and Evans CH: An overview of underlying causes
and animal models for the study of age-related degenerative
disorders of the spine and synovial joints. J Orthop Res.
31:831–837. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Risbud MV and Shapiro IM: Shapiro, role of
cytokines in intervertebral disc degeneration: Pain and disc
content. Nat Rev Rheumatol. 10:44–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Freemont AJ: The cellular pathobiology of
the degenerate intervertebral disc and discogenic back pain.
Rheumatology (Oxford). 48:5–10. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ichikawa Y: Differentiation of a cell line
of myeloid leukemia. J Cell Physiol. 74:223–234. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trouillas M, Saucourt C, Guillotin B,
Gauthereau X, Taupin JL, Moreau JF and Boeuf H: The LIF cytokine:
Towards adulthood. Eur Cytokine Netw. 20:51–62. 2009.PubMed/NCBI
|
|
8
|
Gearing DP, Comeau MR, Friend DJ, Gimpel
SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B,
et al: The IL-6 signal transducer, gp130: An oncostatin M receptor
and affinity converter for the LIF receptor. Science.
255:1434–1437. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nicola NA and Babon JJ: Leukemia
inhibitory factor (LIF). Cytokine Growth Factor Rev. 26:533–544.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carroll GJ and Bell MC: Leukaemia
inhibitory factor stimulates proteoglycan resorption in porcine
articular cartilage. Rheumatol Int. 13:5–8. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Naka T and Kishimoto T: Joint disease
caused by defective gp130-mediated STAT signaling. Arthritis Res.
4:154–156. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bell MC and Carroll GJ: Rheumatoid
synovial fluid contains bioactive leukemia inhibitory factor with
cartilage degrading activity-another target for chondroprotective
intervention. J Rheumatol. 27:332–338. 2000.PubMed/NCBI
|
|
13
|
Lotz M, Moats T and Villiger PM: Leukemia
inhibitory factor is expressed in cartilage and synovium and can
contribute to the pathogenesis of arthritis. J Clin Invest.
90:888–896. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee CR, Sakai D, Nakai T, Toyama K,
Mochida J, Alini M and Grad S: A phenotypic comparison of
intervertebral disc and articular cartilage cells in the rat. Eur
Spine J. 16:2174–2185. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Masuda K, Aota Y, Muehleman C, Imai Y,
Okuma M, Thonar EJ, Andersson GB and An HS: A novel rabbit model of
mild, reproducible disc degeneration by an anulus needle puncture:
correlation between the degree of disc injury and radiological and
histological appearances of disc degeneration. Spine (Phila Pa
1976). 30:5–14. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang X, Hu Z, Hao J and Shen J: Low
intensity pulsed ultrasound promotes the extracellular matrix
synthesis of degenerative human nucleus pulposus cells through
FAK/PI3K/Akt pathway. Spine (Phila Pa 1976). 41:E248–E254. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Upadhyay A, Sharma G, Kivivuori S, Raye
WS, Zabihi E, Carroll GJ and Jazayeri JA: Role of a LIF antagonist
in LIF and OSM induced MMP-1, MMP-3, and TIMP-1 expression by
primary articular chondrocytes. Cytokine. 46:332–338. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahadiat O, Higgins S, Ly A and Wysong A:
Toluidine blue stain of dermatofibrosarcoma protuberans:
Highlighting its use in mohs. Dermatol Surg. 43:1496–1498. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Han B, Zhu K, Li FC, Xiao YX, Feng J, Shi
ZL, Lin M, Wang J and Chen QX: A simple disc degeneration model
induced by percutaneous needle puncture in the rat tail. Spine
(Phila Pa 1976). 33:1925–1934. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vaudreuil N, Kadow T, Yurube T, Hartman R,
Ngo K, Dong Q, Pohl P, Coelho JP, Kang J, Vo N and Sowa G: NSAID
use in intervertebral disc degeneration: What are the effects on
matrix homeostasis in vivo? Spine J. 17:1163–1170. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Daly C, Ghosh P, Jenkin G, Oehme D and
Goldschlager T: A review of animal models of intervertebral disc
degeneration: Pathophysiology, regeneration, and translation to the
clinic. Biomed Res Int 2016. 59521652016.
|
|
22
|
Liu H-T, Wang W-M, Lin Z-J, Chen G-X, Lin
G-Y and Li P-S: Alterations in imaging and histopathology after
aspiration of nucleus pulposus of rabbit lumbar intervertebral
disc. J Clin Rehabil Tissue Eng Res. 18:1313–1318. 2014.
|
|
23
|
Upadhyay A, Senyschyn D, Santos L, Gu R,
Carroll GJ and Jazayeri JA: K/BxN serum transfer arthritis is
delayed and less severe in leukaemia inhibitory factor
(LIF)-deficient mice. Clin Exp Immunol. 169:71–78. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang Y, Xiao Q, Hu Z, Pu B, Shu J, Yang
Q, Lao H and Hao J: Tissue levels of leukemia inhibitory factor
vary by osteoarthritis grade. Orthopedics. 37:e460–e464. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Adams MA and Roughley PJ: What is
intervertebral disc degeneration, and what causes it? Spine (Phila
Pa 1976). 31:2151–2161. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Videman T, Gibbons LE and Battié MC:
Age-and pathology-specific measures of disc degeneration. Spine
(Phila Pa 1976). 33:2781–2788. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Terry DE, Chopra RK, Ovenden J and
Anastassiades TP: Differential use of Alcian blue and toluidine
blue dyes for the quantification and isolation of anionic
glycoconjugates from cell cultures: Application to proteoglycans
and a high-molecular-weight glycoprotein synthesized by articular
chondrocytes. Anal Biochem. 285:211–219. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Silacci P, Dayer JM, Desgeorges A, Peter
R, Manueddu C and Guerne PA: Interleukin (IL)-6 and its soluble
receptor induce TIMP-1 expression in synoviocytes and chondrocytes,
and block IL-1-induced collagenolytic activity. J Biol Chem.
273:13625–13629. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tilg H, Dinarello CA and Mier JW: IL-6 and
APPs: Anti-inflammatory and immunosuppressive mediators. Immunol
Today. 18:428–432. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nemoto O, Yamada H, Mukaida M and Shimmei
M: Stimulation of TIMP-1 production by oncostatin M in human
articular cartilage. Arthritis Rheum. 39:560–566. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Metcalf D: Leukemia inhibitory factor-a
puzzling polyfunctional regulator. Growth factors. 7:169–173. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wilks AF: Two putative protein-tyrosine
kinases identified by application of the polymerase chain reaction.
Proc Natl Acad Sci USA. 86:1603–1607. 1989. View Article : Google Scholar : PubMed/NCBI
|
